Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares dipped Wednesday, as the patient-focused clinical-stage biopharmaceutical company announced its collaboration with Washington University School of ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, today announced its collaboration with Washington University School of Medicine in St. Louis to ...

A recent study demonstrated the potential of gene therapy to restore motor capacity in an ultra-rare disease, megalencephalic ...

A recent study led by the UAB demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, ...

A recent study led by the Universitat Autònoma de Barcelona (UAB) demonstrates the potential of gene therapy to restore motor ...

A receptor that cannabis latches onto in the brain could be a promising target for future mental health treatments.

The equity financing is at a 10% premium to the market share price1 ZÜRICH, SWITZERLAND / ACCESS Newswire / March 31, 2025 / NLS Pharmaceutics Ltd.(NASDAQ:NLSP) ("NLS" or the "Company"), a Swiss ...

Glaucoma Research Foundation (GRF) announced the nine recipients of its $55,000 one-year Shaffer Research Grants. "We are extremely fortunate for the ongoing and generous investment from our glaucoma ...

The authors have generated important resources such as a reference dataset of early primate development by utilizing single-cell transcriptomic technology together with induced pluripotent stem cells ...

Here, authors present an approach by integrating astrocyte-secreted factors to facilitate maturation and functional fidelity of in vitro brain organoids and planar neural cultures.

The Royal Alberta Museum 'Connections' exhibition is a collaboration between the U of A's NMHI and the faculty of arts.